A postdoctoral fellowship opportunity is available in the Division of Systems Biology, Biomarkers and Alternative Models Branch at the National Center for Toxicological Research (NCTR) on the Jefferson Laboratories Campus of the U.S. Food and Drug Administration (FDA) located in Jefferson, Arkansas with a joint research station at the University of Tennessee Health Science Center (UTHSC) Regional Biocontainment Laboratory (RBL) in Memphis, Tennessee.
The NCTR, located approximately 35 miles southeast of Little Rock, Arkansas, conducts FDA mission-related research that is of critical importance to the Agency in developing a scientifically sound basis for regulatory decisions. Over 110 Ph.D. scientists and 400 support scientists, on-site contractors and administrative staff make up a dynamic group of professionals in the NCTR organization. Undergraduate and graduate students, post-doctoral fellows and visiting scientists also pursue education and research opportunities in a multi-disciplinary team atmosphere. For more information on NCTR research and training activities, visit http://www.fda.gov/NCTR.
The participant will use a combination of pathological and toxicological approaches to evaluate potential effects of SARS-CoV-2 infection and therapeutic administration in a COVID-19 animal model during pregnancy and during development. S/he will have dual research stations at the UTHSC RBL in Memphis, TN and the FDA NCTR campus in Jefferson, AR. S/he will be expected to collaborate with FDA investigators at the NCTR, with investigators at UTHSC, and with investigators in other FDA Centers/Offices. During the project, s/he will be actively encouraged to present the research at internal and external meetings and publish the findings in peer-reviewed journals.
The initial appointment is for one year, but may be renewed upon recommendation and is contingent on the availability of funds. The appointment is full-time at FDA in Jefferson, AR and Memphis, TN areas. Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA. OPM can complete a background investigation only for individuals, including non-US citizens, who have resided in the US for a total of the three of the past five years.
The participant will receive a monthly stipend commensurate with education level and experience. Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, Department of Energy or the program administrator, and there are no employment-related benefits.
Qualified candidates should have received a doctoral degree in one of the relevant fields, or be currently pursuing the degree with completion by the anticipated appointment start date. Degree must have been received within five years of the appointment start date.
Preferred skills: knowledge in the area of reproductive and developmental biology, toxicology, and/or cellular biology. Prior experience in reproductive and developmental biology is desired, especially with additional training/experience in toxicology, neurobiology, infectious diseases, molecular and cellular biology, or a related field. Preference will be given to individuals with a demonstrated record of relevant accomplishments, which include written and oral communication skills, ability for teamwork and experience working with rodents and/or embryos.
Interested individuals should apply on-line through the Zintellect website (https://www.zintellect.com) powered by the Oak Ridge Institute for Science and Education (reference code FDA-NCTR-2021-0004). Interested applicants may also contact Jessica Hawes (Jessica.email@example.com) and/or Amy Inselman (firstname.lastname@example.org), Division of Systems Biology, National Center for Toxicological Research/FDA for more information.
Application deadline: 02/12/2021. Applications will be accepted until the appointment is filled.
FDA/NCTR is a smoke free environment.